Related Experiment Video
Updated: Jul 27, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
Rhythmic auditory stimulation as a potential neuromodulator for Parkinson's disease
Yuko Koshimori1, Michael H Thaut1
1Music and Health Science Research Collaboratory, Faculty of Music, University of Toronto, 90 Wellesley Street West, Toronto, ON, M5S 1C5, Canada.
Parkinsonism & Related Disorders
|June 5, 2023
Summary
Rhythmic auditory stimulation (RAS) improves gait, balance, and fall prevention in Parkinson's disease (PD). Emerging research suggests RAS also modulates brain oscillations, potentially benefiting other PD symptoms and atypical parkinsonism.
Area of Science:
- Neuroscience
- Neurology
- Rehabilitation Medicine
Background:
- Idiopathic Parkinson's disease (PD) significantly impacts gait and balance, increasing fall risk.
- Rhythmic auditory stimulation (RAS) is an established intervention for motor impairments in PD.
- Growing evidence suggests RAS influences neural activity and brain oscillations.
Purpose of the Study:
- To review the efficacy of auditory rhythm-based interventions, specifically RAS, in improving motor function in PD.
- To explore the underlying neuromodulatory mechanisms of RAS, including neural entrainment and cross-frequency coupling.
- To discuss the potential extension of RAS to other parkinsonian syndromes.
Main Methods:
- Systematic review of studies on RAS for PD motor symptoms.
- Analysis of research investigating RAS effects on brain oscillations.
- Discussion of neurophysiological mechanisms like neural entrainment and cross-frequency coupling.
Main Results:
- RAS demonstrates effectiveness in enhancing gait and balance in idiopathic PD.
- RAS contributes to fall prevention in individuals with PD.
- Emerging data indicate RAS-induced neuromodulation of brain oscillations.
Conclusions:
- Auditory rhythm interventions, particularly RAS, offer significant benefits for PD motor symptoms.
- Neuromodulation via neural entrainment and cross-frequency coupling may underlie RAS efficacy.
- RAS interventions show promise for broader application in atypical parkinsonism.
Related Concept Videos
Parkinson's Disease: Treatment
305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305
Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K

